Friday, July 10, 2026

Drug profile · INN

embolic

embolic is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 1
Pipeline programs 8
News articles 0
Drug details — embolic
Class
Route
Patents
1
Programs
8
Data quality
0.70

Quick answer

embolic is an FDA-listed pharmaceutical active ingredient.

Key facts

INN embolic

Approval history

Authority Status Date
NMPA clinical trials

Pipeline programs

  1. R7508-DVT-24116 Phase 3 · Anaxis Pharma · Thromboembolic disease
  2. Riociguat Phase 3 · Chinese Academy of · Chronic Thromboembolic Pulmonary Hypertension
  3. Placebo de macitentan 10 mg, MACITENTAN Phase 2 · PARItec · Inoperable Chronic thromboembolic pulmonary hyperTension, Pn
  4. R7508-DVT-2360 Phase 2 · Anaxis Pharma · Thromboembolic disease
  5. 22375 Phase 1 · Bayer · Prevention of ischemic stroke in patients after an acute non
  6. 22665 Phase 1 · Bayer · Prevention of ischemic stroke in patients post acute non-car
  7. A study to compare the amount of milvexian in... Phase 1 · Janssen-Cilag International N.V · atherothrombotic and thromboembolic disorders
  8. Asundexian Bayer 10mg Granules, BAY 2433334 Phase 1 · Bayer · Prevention of thromboembolic events

Related patents

  1. US 11672876

    Imageable embolic microsphere

    Expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is embolic?

embolic is an FDA-listed pharmaceutical active ingredient.